Stemina biomarker discovery

SBIR Phase II: Metabolomics of Human Embryonic Stem Cells to ...

[email protected]. Recipient Sponsored Research Office: Stemina Biomarker Discovery, inc. 504 S ROSA RD MADISON WI US 53719-1218 (608)204-0104. Sponsor ...

Autism Metabolome Project and Clinical Study

Stemina Biomarker Discovery received support from the NLM Family Foundation for a clinical study of biomarkers in the blood of children with autism spectrum ...

Stemina Eyes Dx Future through Stem Cells-Metabolomics Approach

NEW YORK (GenomeWeb News) – Leveraging one of the newer 'omics fields along with stem cell technology, start-up firm Stemina Biomarker Discovery ...

Agilent Technologies and Stemina Biomarker Discovery Announce ...

Stemina uses metabolomic analysis of stem cells for the discovery of biomarkers for use in drug screening, drug development and drug development ...

Stemina Poster: A Human Pluripotent Stem Cell-based Assay ...

Stemina Biomarker Discovery, Madison, WI, United States;. 2. The Netherlands Organization for Applied Scientific Research (TNO), The Hague, Netherlands;. 3.

Venture Round - Stemina Biomarker Discovery - Crunchbase

Stemina Biomarker Discovery raised $3100000 on 2017-01-01 in Venture Round.

Directions to Stemina Biomarker Discovery Inc - MapQuest

Driving directions to Stemina Biomarker Discovery Inc, 504 S Rosa Rd, Madison, WI including road conditions, live traffic updates, and reviews of local ...

Stemina Biomarker Discovery Launches Largest Ever Clinical Study ...

Stemina Biomarker Discovery Inc. today announced the launch of the largest clinical study of the metabolism of children with autism spectrum ...

An Unbiased Metabolomics Approach to Create and Apply Targeted ...

Targeted Biomarker Assays in Human Stem Cell Models. Stemina Biomarker Discovery, Inc. 504 S. Rosa Rd., Suite 150, Madison WI. 53719. Laura A ...

CIT and Stemina Biomarker Discovery Announce Partnership in ...

CIT and Stemina Biomarker Discovery Announce Partnership in Europe for Stem Cell based Toxicology Testing. News. Published: February 21, 2011.

stemina-raises-additional-funding-for-autism-work

Stemina Biomarker Discovery Inc., a Madison company focused on diagnosis and individualized treatment of neurological disorders, has raised additional outside ...

Stemina Biomarker Discovery - X.com

Come to our #2022SOT Poster Session Today at 9:00am PST! “devTOX quickPredict Accurately Predicts the Developmental Toxicity Potential of ...

Current Research in Toxicology | Article collections

David Belair (AbbVie Inc, USA), Jessica Palmer (Stemina Biomarker Discovery Inc. USA) and Nicole zur Nieden (UC Riverside, USA) together with Current ...

CIT to Distribute Stemina's hESC-Based Toxicity Assay

CIT – Safety and Health Research Laboratories and Stemina Biomarker Discovery inked a strategic partnership under which CIT will distribute ...

A Metabolism-Based Test to Diagnose Autism Spectrum Disorder ...

Burrier, Robert E. / Stemina Biomarker Discovery, Inc. $892,872. Comments. Be the first to comment on Robert Burrier's grant.

Stemina Biomarker Discovery - Estonia Innovation Ecosystem

Stemina Biomarker Discovery, and commercializes molecular biomarkers to improve drug safety and human health. Here you'll find information about their ...

Promega and Stemina Biomarker Discovery Announce Collaboration

Research Triangle Park, N.C. –February 17, 2015 – EpiCypher today announced the launch of a new version of EpiCypher.com.

Stemina and CIT join forces for stem cell based toxicology testing

Contract science-driven research organisation CIT Safety and Health Research Laboratories and Stemina Biomarker Discovery Inc have entered ...

Stemina's Human Induced Pluripotent Stem Cell Test Predicts Drug ...

MADISON, Wis.--(BUSINESS WIRE)--Stemina Biomarker Discovery, Inc., today announced study results showing the high performance of the ...

Identification of Biomarkers of Cardiotoxicity using Metabolomics of ...

... Stemina Biomarker Discovery andquot Steminaandquot proposes to use metabolomics of human induced pluripotent stem cell derived ...